To report a case of microtrauma-induced recurrent hyphema and secondary glaucoma associated with voluntary chronic acetylsalicylic acid (ASA) use. A 43-year-old male developed advanced glaucoma in his right eye after a two-month followup period of recurrent microhyphema, which had been induced by strong eye-rubbing. In spite of topical and systemic antiglaucoma medication, as well as topical corticosteroid and cycloplegic drugs and bed rest under hospitalization, the hyphema and glaucoma were not controlled. His medical history revealed that he had been using ASA for 2 years in order to prevent heart attacks. We asked the patient to stop ASA intake and the hyphema cleared considerably on the third day after discontinuation of the drug. One week after stopping ASA, trabeculectomy with mitomycin C was performed without any complications. Glaucoma and recurrent hyphema were controlled after surgery without any medical treatment. Chronic ASA intake may cause recurrent hyphema and secondary glaucoma even after a microtrauma. Medical histories of patients must always be taken, especially in cases of prolonged recurrent hyphema.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10792-012-9517-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Delayed onset Spontaneous Hyphema after OMNI® Surgical System.
J Glaucoma
October 2024
Department of Ophthalmology, Mayo Clinic 200 First St SW, Rochester, MN, 55905.
Minimally invasive glaucoma surgery (MIGS) offers options for glaucoma treatment that have generally improved safety profiles compared with filtering surgery. MIGS vary in design and procedure, but all angle-based MIGS function by bypassing or removing aqueous humor outflow resistance at the level of the trabecular meshwork. This can lower intraocular pressure but also remove the blood-aqueous barrier.
View Article and Find Full Text PDFA case of delayed recurrent hyphema following Implantable Collamer Lens (ICL) surgery.
Am J Ophthalmol Case Rep
December 2024
The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Prevention and Treatment on Major Blinding Diseases, Chongqing Eye Institute, Chongqing Branch (Municipality Division) of National Clinical Research Center for Ocular Diseases, Chongqing, 400016, PR China.
Purpose: To present a case of delayed recurrent hyphema following toric ICL implantation.
Observations: This case reports a 24-year-old Asian female who presented with sudden decrease in vision in the right eye, accompanied by recurrent massive anterior chamber hemorrhage, six months after bilateral implantation of toric ICL with central holes for myopia correction. Despite initial conservative treatment with immobilization and intraocular pressure (IOP)-lowering medication at another hospital, the hyphema persisted.
Neovascular Glaucoma: A Rare Presenting Feature of Vogt-Koyanagi-Harada Syndrome.
Cureus
July 2024
Ophthalmology, All India Institute of Medical Sciences, Nagpur, IND.
Article Synopsis
- Vogt-Koyanagi-Harada syndrome (VKH) is a rare autoimmune disorder that causes severe inflammation in multiple systems, primarily affecting the eyes and leading to symptoms like visual loss and skin changes.
- A 20-year-old male patient experienced rapid vision loss due to granulomatous panuveitis and was treated for complications like cataracts and glaucoma, but only later showed signs of vitiligo and poliosis that confirmed VKH.
- This case emphasizes that VKH can present atypically with glaucoma as the first symptom, highlighting the need for early diagnosis to prevent significant vision loss.
Objective: To determine the causes, time to resolution, effect of therapeutics, and ocular sequelae of hyphema, fibrin, and/or vitreal hemorrhage in horses.
Animals: 225 horses (219 eyes) who were diagnosed with hyphema, fibrin, and/or vitreal hemorrhage.
Methods: Records were retrospectively reviewed for the horses.
Uveitis-Glaucoma-Hyphema Syndrome From Subtle Malposition of a Hydrus Microstent.
J Glaucoma
November 2024
Department of Ophthalmology, Moran Eye Center, University of Utah, Salt Lake City, UT.
Uveitis-glaucoma-hyphema (UGH) syndrome is a rare condition characterized by intraocular inflammation, elevated intraocular pressure, and recurrent hyphema. Although UGH syndrome is typically caused by chafing between an intraocular lens and the iris or ciliary body, microinvasive glaucoma devices are becoming increasingly recognized as potential causes of recurrent intraocular inflammation. Herein, we discuss a case of UGH syndrome due to the subtle malposition of a Hydrus microstent that ultimately required surgical removal to manage.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!